5 Amino 1MQ Peptide Dosage Chart

Overview

If you are researching 5 amino 1mq, the most important point is simple: there is no established, evidence-based human dose for this compound. Although people often search for a 5 amino 1mq peptide protocol, 5-amino-1MQ is generally described in the literature as a small-molecule nicotinamide N-methyltransferase inhibitor, not a traditional peptide, and the available dosing evidence comes mainly from cell and mouse studies rather than approved human use. (pmc.ncbi.nlm.nih.gov)

That does not mean the topic is useless to understand. It means the safest, most practical way to discuss 5-amino-1mq dosage is to separate published research doses from internet dosing claims, and to be clear that research doses should not be treated as self-injection instructions. You can use our 5 amino 1MQ dosage calculator → to convert published animal research doses and check reconstitution math — for educational comparison only, not for self-dosing.

What is 5 amino 1mq, and is it really a peptide?

5 amino 1mq is commonly marketed in the peptide world, but it is more accurately described as 5-amino-1-methylquinolinium, a small molecule investigated for its ability to inhibit NNMT. NNMT is an enzyme involved in nicotinamide metabolism, methylation balance, and pathways connected to cellular energy handling. Early interest grew because NNMT activity has been linked with adipose tissue and metabolic dysfunction in experimental models. (nature.com)

In practical terms, the phrase "5 amino 1mq peptide" is more of a marketplace label than a precise scientific classification. That distinction matters because peptide dosing habits do not automatically apply to a non-peptide small molecule. A vial, capsule, or online "protocol" may look familiar, but the pharmacology, safety questions, absorption, and dose translation can be very different.

The evidence-based dosage picture is limited

The strongest public dosing information for 5-amino-1MQ comes from preclinical research. One mouse study in diet-induced obesity used subcutaneous dosing three times daily for 11 days, while a later study evaluated once-daily dosing for 28 days and reported dose-dependent metabolic effects in obese mice. These are research findings in animals, not validated human treatment protocols. (pmc.ncbi.nlm.nih.gov)

This is why responsible dosage guidance has to sound less exciting than many online posts. There is no FDA-approved 5-amino-1MQ product label, no standard clinical titration schedule, and no published human trial that establishes a safe or effective daily dose for body composition, weight loss, NAD+ support, or any other indication.

5-amino-1MQ dosage chart based on published research

The chart below summarizes the clearest available dosing information. It is not a recommendation for personal use and should not be used to calculate a home 5 amino 1mq injection dosage. If you want to see the BSA-based dose conversion math, use our 5 amino 1MQ dosage calculator → — but only for educational comparison, never for self-injection.

Source	Dose	Route	Duration	Practical Meaning
Human clinical use	None established	No approved route	N/A	A human 5-amino-1mq dosage cannot be responsibly recommended from current evidence
Diet-induced obese mice (11-day)	20 mg/kg per injection	Subcutaneous, 3x daily	11 days	Animal research regimen, not a human injection protocol (pmc.ncbi.nlm.nih.gov)
Diet-induced obese mice (28-day)	10-32 mg/kg/day	Subcutaneous, once daily	28 days	Supports further research but does not establish a human dose (pubmed.ncbi.nlm.nih.gov)
Cell and mechanistic research	Micromolar concentrations	In vitro	Varies	Cell concentrations should never be treated as supplement or injection dosing guidance

Human clinical use

• Recommended dose: None established.
• Route: No approved oral or injectable route.
• Context: No validated human dose is available from approved labeling or published human clinical trials.
• Practical meaning: A human 5-amino-1mq dosage cannot be responsibly recommended from current evidence.

Diet-induced obese mice, 11-day study

• Research dose: 20 mg/kg per injection, subcutaneous, three times daily.
• Reported total: Approximately 34 mg/kg/day of parent compound when calculated by free weight.
• Context: Used in a controlled animal model to evaluate NNMT inhibition and obesity-related outcomes.
• Practical meaning: This is an animal research regimen, not a human injection protocol. (pmc.ncbi.nlm.nih.gov)

Diet-induced obese mice, 28-day study

• Research dose: 10 mg/kg/day and 32 mg/kg/day, subcutaneous, once daily.
• Context: Used to assess body composition, glucose tolerance, insulin sensitivity, liver markers, pharmacokinetics, and tissue distribution.
• Practical meaning: The study supports further research, but it still does not establish a human dose. (pubmed.ncbi.nlm.nih.gov)

Cell and mechanistic research

• Research exposure: Micromolar concentrations are reported in experimental settings.
• Context: Cell data can help explain mechanism, but it does not convert cleanly into milligrams for humans.
• Practical meaning: Cell concentrations should never be treated as supplement or injection dosing guidance.

Why mouse doses do not become human doses overnight

Animal-to-human dose translation is not a simple matter of multiplying a mouse dose by a person's body weight. FDA guidance for first-in-human studies uses body-surface-area concepts, human-equivalent dose calculations, no-observed-adverse-effect levels, and safety factors; even then, those calculations are part of formal drug development, not a shortcut for consumer dosing. (fda.gov)

This is especially relevant for 5 amino 1mq because the published animal studies were designed for controlled research environments. Researchers know the compound identity, route, timing, animal strain, diet model, endpoints, and monitoring plan. A person buying a product online usually does not have that level of quality control or medical supervision. Our 5 amino 1MQ dosage calculator → demonstrates the BSA conversion process, but even the converted result is not a validated human dose.

Injection dosage claims deserve extra caution

Searches for 5 amino 1mq injection dosage often lead to conflicting numbers, usually without a clear source. Some claims appear to borrow from animal studies, while others come from community anecdotes, clinic-style protocols, or supplier marketing. None of these substitutes for human pharmacokinetic and safety data.

Injection also adds risks that oral discussion sometimes overlooks. Sterility, solvent choice, pH, concentration, injection-site tolerance, contamination, and dosing accuracy all matter. With an unapproved compound, those variables may be uncertain even before considering the biological effects of NNMT inhibition.

A practical safety checklist for evaluating any 5 amino 1mq claim:

• Does the source clearly distinguish animal research from human use?
• Does it cite a published study rather than a forum post or sales page?
• Does it explain route, frequency, duration, and compound form?
• Does it acknowledge that no validated human dose exists?
• Does it avoid promising fat loss, NAD+ benefits, or metabolic results without human data?
• Does it recommend medical oversight rather than self-experimentation?

A practical way to read 5 amino 1mq research

If you are reviewing 5 amino 1mq for educational purposes, focus less on "What dose should I take?" and more on "What has actually been tested?" That shift keeps the conversation grounded.

Useful questions include:

1. Was the study done in humans, animals, or cells? Human evidence carries different practical weight than mouse or cell data.

2. What route was used? Subcutaneous mouse dosing does not prove that oral capsules or human injections will behave the same way.

3. How long was the study? An 11-day or 28-day mouse experiment cannot answer long-term human safety questions.

4. What outcomes were measured? Body composition, insulin markers, tissue distribution, and liver histology are different endpoints.

5. Was safety the main purpose? Efficacy-focused animal studies are not the same as full toxicology packages.

The bottom line on 5-amino-1mq dosage

The most accurate 5-amino-1mq dosage answer is that no recommended human dose has been established. Published research provides animal dosing ranges, including subcutaneous mouse regimens, but those numbers should not be treated as personal dosing instructions.

For now, 5 amino 1mq is best understood as an experimental NNMT inhibitor with interesting preclinical metabolic research and significant unanswered safety questions. If you are considering any unapproved compound, especially an injectable one, discuss it with a qualified medical professional and be wary of protocols that present animal data as ready-made human dosing advice. Our 5 amino 1MQ dosage calculator → can help you understand the conversion math, but the medical decision belongs to a qualified clinician.

Frequently Asked Questions

Related Guides